treatment of autosomal dominant polycystic kidney disease
All entries for: AstraZeneca Pharmaceuticals LP
July 8, 2026
AstraZeneca Pharmaceuticals LP
Orphan Drug Designation
Disease Area: Rare Diseases
March 9, 2026
AstraZeneca Pharmaceuticals LP
Orphan Drug Designation
treatment of idiopathic pulmonary fibrosis
Disease Area: Rare Diseases
February 20, 2026
AstraZeneca Pharmaceuticals LP
Orphan Drug Designation
treatment of follicular lymphoma
Disease Area: Rare Diseases